Näytä suppeat kuvailutiedot

dc.contributor.authorLöfberg, Ida E.
dc.contributor.authorKarppinen, Jari E.
dc.contributor.authorLaatikainen-Raussi, Vesa
dc.contributor.authorLehti, Maarit
dc.contributor.authorHackney, Anthony C.
dc.contributor.authorIhalainen, Johanna K.
dc.contributor.authorMikkonen, Ritva S.
dc.date.accessioned2024-08-28T04:58:07Z
dc.date.available2024-08-28T04:58:07Z
dc.date.issued2024
dc.identifier.citationLöfberg, I. E., Karppinen, J. E., Laatikainen-Raussi, V., Lehti, M., Hackney, A. C., Ihalainen, J. K., & Mikkonen, R. S. (2024). Resting Energy Expenditure, Metabolic and Sex Hormones in Two Phases of the Menstrual and Hormonal Contraceptive Cycles. <i>Medicine and Science in Sports and Exercise</i>, <i>ahead of Print </i>. <a href="https://doi.org/10.1249/mss.0000000000003518" target="_blank">https://doi.org/10.1249/mss.0000000000003518</a>
dc.identifier.otherCONVID_233351847
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/96775
dc.description.abstractIntroduction Resting energy expenditure (REE) may fluctuate during the menstrual cycle (MC), due to the physiological effects of estradiol (E2) and progesterone (P4). This study examined changes in REE and metabolic hormones (leptin, ghrelin, thyroid hormones), and dietary intake in two hormonally distinct groups, naturally menstruating women (NoOC) and women using monophasic combined oral contraceptives (COC). Methods Measurements included REE by indirect calorimetry, body composition by bioimpedance, and blood samples for hormone analysis in the early follicular and mid-luteal phases of the MC in NoOC-group (n = 38) or the active and inactive phases of the COC cycle (COC, n = 19). Participants recorded their food intake for 3 days after measurements. A secondary analysis was completed for the NoOC-group without REE outliers (difference between measurements >1.5 × interquartile range, n = 4). Results In the NoOC-group, luteal phase REE was 40 kcal higher than follicular phase REE [95% confidence interval (CI): -2 kcal/d–82 kcal/d, d = 0.20, p = 0.061]. Leptin (d = 0.35, p < 0.001), T3 (d = 0.26, p = 0.05) and fat intake (d = 0.48, p = 0.027) were lower, and T4 (d = 0.21, p = 0.041) was higher in the luteal phase. After excluding outliers, REE was 44 kcal higher in the luteal phase than in the follicular phase (95% CI: 12 kcal/d–76 kcal/d, d = 0.22, p = 0.007). In the COC-group, the mean difference in REE was -2 kcal (95% CI-82 kcal/d–79 kcal/d) between active and inactive phases, while T3 was higher in the inactive phase (d = 0.01, p = 0.037). Conclusions REE increases only slightly from the follicular to the luteal phase but remains unchanged between COC phases. Increases in T3, leptin, and fat intake during the luteal phase might echo metabolic fluctuations that parallel female sex hormones during the MC.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofseriesMedicine and Science in Sports and Exercise
dc.rightsCC BY-NC-ND 4.0
dc.subject.otherfemale physiology
dc.subject.otherenergy intake
dc.subject.otherhormonal contraception
dc.subject.otherreproductive hormones
dc.subject.otherresting metabolism
dc.titleResting Energy Expenditure, Metabolic and Sex Hormones in Two Phases of the Menstrual and Hormonal Contraceptive Cycles
dc.typeresearch article
dc.identifier.urnURN:NBN:fi:jyu-202408285662
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn0195-9131
dc.relation.volumeahead of Print
dc.type.versionacceptedVersion
dc.rights.copyright© 2024 American College of Sports Medicine
dc.rights.accesslevelopenAccessfi
dc.type.publicationarticle
dc.subject.ysokuukautiskierto
dc.subject.ysonaiset
dc.subject.ysoraskauden ehkäisy
dc.subject.ysoaineenvaihdunta
dc.subject.ysoenergiansaanti
dc.subject.ysoenergiankulutus (aineenvaihdunta)
dc.subject.ysofysiologia
dc.subject.ysohormonit
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p38920
jyx.subject.urihttp://www.yso.fi/onto/yso/p16991
jyx.subject.urihttp://www.yso.fi/onto/yso/p2237
jyx.subject.urihttp://www.yso.fi/onto/yso/p3066
jyx.subject.urihttp://www.yso.fi/onto/yso/p27286
jyx.subject.urihttp://www.yso.fi/onto/yso/p24540
jyx.subject.urihttp://www.yso.fi/onto/yso/p2317
jyx.subject.urihttp://www.yso.fi/onto/yso/p2589
dc.rights.urlhttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.relation.doi10.1249/mss.0000000000003518
jyx.fundinginformationThe study was funded by the Finnish Ministry of Education and Culture and Firstbeat Analytics Oy. In addition, Garmin Venu 2S watches and Garmin HRM-dual heart rate belt heart rate monitors were provided by Firstbeat Analytics Oy. Expense funding for blood analyses was received from the Suomen Urheilututkimussäätiö.
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY-NC-ND 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY-NC-ND 4.0